Interpretation 'after the conduct of the study' ref:Guideline of BABE CDSCO [Regulatives / Guidelines]

posted by ravi.shah206 – India, 2016-12-02 08:22 (2674 d 03:56 ago) – Posting: # 16823
Views: 2,384

Dear All,

Can anyone give the interpretation of following clause as per CDSCO 'Guideline for Bioavailability & Bio equivalence Studies'.

Section 8: Retention of BA/BE samples
All samples of Test and reference drug products used in bioavailability / bioequivalence study should be retained for a period of three years after conduct of the study or one year after the expiry of the drug.

Specifically, what should be "after conduct of the study"?

whether should be after sign off the final CSR?
or after last study specific data collected?
or after last dosing of last period?
or anything else?

Regards.
Ravi.

Complete thread:

UA Flag
Activity
 Admin contact
22,957 posts in 4,819 threads, 1,636 registered users;
110 visitors (0 registered, 110 guests [including 7 identified bots]).
Forum time: 12:18 CET (Europe/Vienna)

With four parameters I can fit an elephant,
and with five I can make him wiggle his trunk.    John von Neumann

The Bioequivalence and Bioavailability Forum is hosted by
BEBAC Ing. Helmut Schütz
HTML5